Cost-Benefit Analysis of the Introduction of Mp-Mri Guided Biopsies in Croatia
- PMID: 30457247
- PMCID: PMC12231100
- DOI: 10.20471/acc.2018.57.s1.06
Cost-Benefit Analysis of the Introduction of Mp-Mri Guided Biopsies in Croatia
Abstract
The objective of this study was to determine differential expression of TFF1, TFF2 and TFF3 genes and proteins in breast tumor subtypes. In addition, we investigated the correlation between TFF genes within tumor subgroups, and TFF genes with clinical and pathologic characteristics of the tumor. Study group included 122 patients with surgically removed breast tumors. Samples were investigated using qRT-PCR and immunohistochemistry. TFF1 and TFF3 genes and proteins were expressed in breast tumors, while the levels of TFF2 gene and protein expression were very low or undetectable. TFF1 was significantly more expressed in benign tumors, while TFF3 was more expressed in malignant tumors. Gene and protein expression of both TFF1 and TFF3 was greater in lymph node-negative tumors, hormone positive tumors, tumors with moderate levels of Ki67 expression, and in grade II tumors. A strong positive correlation was found between TFF1 and TFF3 genes, and the expression of both negatively correlated with Ki67 and the level of tumor histologic differentiation. Our results suggest that TFF1 and TFF3, but not TFF2, may have a role in breast tumor pathogenesis and could be used in the assessment of tumor differentiation and malignancy.
Keywords: Prostate cancer, cost benefit; Prostate mp-MRI.
References
-
- White J. (2010). The cost of health care in Western countries. Oxford Medicine Online. doi: https://doi.org/10.1093/med/9780199204854.003.030401. 10.1093/med/9780199204854.003.030401 - DOI
-
- Getzen TE. Getzen Model of Long-Run Medical Cost Trends, 2017 Society of Actuaries (Internet) [cited 2018 Jan 5]. Available from: https://www.soa.org/research-reports/2016/research-hlthcare-trends/.
-
- Juday TR. Cost-effectiveness Analysis: Problems and Promise for Evaluating Medical Technology. Health Care Technology Policy I: The Role of Technology in the Cost of Health Care. 1994, pp.462-467. https://doi.org/10.1109/HCTP.1994.721326. 10.1109/HCTP.1994.721326 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical